Women’s Health Behaviours Following Referral to 3 Different

Slides:



Advertisements
Similar presentations
Associations between Obesity and Depression by Race/Ethnicity and Education among Women: Results from the National Health and Nutrition Examination Survey,
Advertisements

Journal Club Alcohol, Other Drugs, and Health: Current Evidence November–December 2014.
Journal Club General Medicine C- 4/3/14
Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2011.
Effectiveness of interactive web-based lifestyle program on prevention of cardiovascular diseases risk factors in patient with metabolic syndrome: a randomized.
Cardiac rehabilitation (CR) uses a multidisciplinary approach and provides a secondary prevention through risk factor identification and modification in.
Cardiovascular Disease in Women Module V: Prognosis and Treatment Outcomes.
Background  Obesity is an extremely common problem ~ 1/3 of adult Americans are obese  Patients commonly ask physicians for advice on weight loss, yet.
Can pharmacists improve outcomes in hypertensive patients? Sookaneknun P (1), Richards RME (2), Sanguansermsri J(1), Teerasut C (3) : (1)Faculty of Pharmacy,
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
END Obesity Dr Gul Bano © S Nussey. What is obesity?
Short Sleep Duration is Associated with Hypertension only among Women: A Population-based Study Stranges S *, Dorn JM *, Cappuccio FP *, Donahue RP *,
Low Fat Center for Energy Balance Journal Club Shannon Armbruster MD Gynecologic Oncology October 15, 2015.
THE ASSOCIATIONS AMONG SOCIAL CAPITAL, HEALTH BEHAVIOURS, AND COGNITIVE MECHANISMS IN CARDIAC OUTPATIENTS Valerie Haboucha 1,2, Darren A Mercer 1,2,3,
1 Improving Care for the Uninsured by Providing Links to Primary Care Susan H. Busch, Ph.D. 1 Sarah McCue Horwitz, Ph.D. 2 Kathleen M. B. Balestracci,
FRagmin® and Fast Revascularization during InStablity in Coronary artery disease FRISC II.
Ross T. Tsuyuki, BSc(Pharm), PharmD, MSc, FCSHP, FACC Yazid NJ Al Hamarneh, BPharm, PhD Charlotte Jones, MD, PhD, FRCP(C) Brenda Hemmelgarn, MD, PhD, FRCP(C)
Clara K. Chow, MBBS, PhD; Julie Redfern, PhD; Graham S. Hillis, MBChB, PhD; Jay Thakkar, MBBS; K arla Santo, MBBS; Maree L. Hackett, PhD; Stephen Jan,
CoRPS Center of Research on Psychology in Somatic diseases Brief Depression Screening with the PHQ-2 Predicts Poor Prognosis following PCI with Drug-Eluting.
Patterns of Depression Screening for Rural Women: Findings from Rural Primary Care Practices Fred Tudiver, MD Joellen Edwards, PhD East Tennessee State.
The OPTImal CArdiac REhabilitation (OPTICARE) trial:
Prof. Dr. Sigmund Silber, FESC, FACC On behalf of the RESOLUTE
Disability After Traumatic Brain Injury among Hispanic Children
- Higher SBP visit-to-visit variability (SBV) has been associated
Symptom management with massage and acupuncture in post-operative cancer patients: A Randomized Controlled Study Wolf Mehling & Bradly Jacobs (PIs)
LOCATION, MODALITY AND DEGREE OF EXERCISE OVER
Angiotensin converting enzyme inhibitors / angiotensin receptor blockers and contrast induced nephropathy in patients receiving cardiac catheterization:
Journal club 24/10/2016 Presented by Pitchayud Kantachuvesiri
Title slide.
Cholesterol Treatment Trialists’ (CTT) Collaboration Slide deck
Sameera Ansari1, Dr Hassan Hosseinzadeh1,
WHERE DO PATIENTS EXERCISE AFTER CARDIAC REHABILITATION?
Participants 18year old+
Rabia Khalaila, RN, MPH, PHD Director, Department of Nursing
Appropriateness of the metabolic equivalent (MET) as an estimate of
Quality of Medical Care Received by Individuals with Mental Illnesses
Changes in Physical Activity Among Participants of the Traditions of the Heart Intervention Traditions of the Heart is a CDC funded cardiovascular screening.
When Military Fitness Standards No Longer Apply
Peer-led Diabetes Prevention Program for TASC in Melbourne
Cholesterol Treatment Trialists’ (CTT) Collaboration Slide deck
Suitability and Tolerability of Mindfulness-Oriented Interventions in Older and Younger Psychiatric Inpatients: A Pilot Study Katerina Nikolitch, MD1,
Veterans with life-limiting illness: Baseline descriptors
Guadalupe X. Ayala, PhD, MPH1 Jose Loredo, MD2 Elva Arredondo, PhD1
College of Nursing ● University of Kentucky ● Lexington, KY
Volume 1: Chronic Kidney Disease Chapter 5: Acute Kidney Injury
Ruth McCullagh Physiotherapy, UCC
Healthy Eating Predicts Lower Risks of Cardiometabolic Diseases in Chinese A report from the Shanghai Women’s and Men’s Health Studies Danxia Yu1, Xiao-Ou.
Don’t Nudge Me: The Limits of Behavioral Economics in Medicine
Effectiveness of support to increase physical activity
POISE-2 PeriOperative ISchemic Evaluation-2 Trial
Effectiveness of a Shared Decision Making Intervention for Patients Offered a Destination Therapy Left Ventricular Assist Device for End-Stage Heart.
Alcohol, Other Drugs, and Health: Current Evidence May-June, 2018
Jeff Macemon Waikato Cardiothoracic Unit
PROPPR Transfusion of Plasma, Platelets, and Red Blood Cells in a 1:1:1 vs a 1:1:2 Ratio and Mortality in Patients With Severe Trauma. 
SocioEconomic Position Contact:
Statins Evaluation in Coronary procedUres and REvascularization
2018 Annual Data Report Volume 1: Chronic Kidney Disease
Cardiac Rehabilitation Program Adherence and Functional Capacity Among Women: A Randomized Controlled Trial  Sherry L. Grace, PhD, Liz Midence, MSc, Paul.
This series of slides highlights a report based on a presentation at the Late-Breaking Trial Sessions of the 2005 American Heart Association Scientific.
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
MMOVeS: Managing Mobility Outcomes for Vulnerable Seniors
Epidemiological Terms
Lecture 4 Study design and bias in screening and diagnostic tests
AIDS 2018 | Abstract No. TUPDC0102 | Tuesday July 24, 2018
Atlantic Cardiovascular Patient Outcomes Research Team
ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective.
The Heart Truth Delaware Background
Sabrina M. Figueiredo1,3, Alicia Rozensveig3, José A. Morais2, Nancy E
Khai Hoan Tram, Jane O’Halloran, Rachel Presti, Jeffrey Atkinson
Presentation transcript:

Women’s Health Behaviours Following Referral to 3 Different Cardiac Rehabilitation Program Models: A Randomized Controlled Trial Put your Title here clinicaltrials.gov Registration #NCT01019135 L Midence, MSc1; HM Arthur, PhD2; P Oh, MD3; S Brister, MD3; C Chessex, MD3; DE Stewart, MD3; SL Grace, PhD1, 3 1York University, 2Hamilton Health Sciences Centre, 3University Health Network - Ontario, Canada BACKGROUND CVD is the leading cause of death globally Cardiac rehabilitation (CR) participation is associated with significantly lower morbidity and mortality, Benefits are due to, among other factors, adherence to a heart-healthy lifestyle New models of CR have been developed, such as women-only programs, to better meet their needs OBJECTIVE To test whether participation in women-only CR results in significantly better health behaviours when compared to participation in co-ed or home-based CR. RESULTS Participant Characteristics by Post-Program Survey Retention Medication Adherence by Randomized Model Excluded n=1847 (91.6%) Declined n=739 (40.0%) INELIGIBLE: Lives and works too far from CR sites n=375 (20.3%) Does not speak/read English n=196 (10.6%) No cardiac diagnosis or procedure meeting inclusion criteria n=162 (8.8%) Referral to CR program prior to randomization n=100 (5.4%) Musculoskeletal, neuromuscular, vision, cognitive or non-dysphoric psychiatric condition/too ill n=86 (4.6%) Not eligible for home-based CR n=68 (3.7%) Recent participation in CR n=25 (1.4%) Planning to leave the province n=23 (1.2%) Did not consent to randomization n=20 (1.1%) Discharged to long-term care n=17 (1.0%) Enrolled in other study with behavioral intervention n=8 (0.4%) Patient passed away n=5 (0.3%) Physician clearance not received n=5 (0.3%) Other n=18 (1.0%) Allocation Enrollment Randomized n=169 (8.4%) Assessed for eligibility n= 2016 Analysis Returned T2 survey=38 (69.1%) Returned T2 pedometer=21 (38.2%) Returned T2 survey=36 (65.5%) Returned T2 pedometer=19 (34.5%) Follow-Up Returned T2 survey=42 (71.2%) Returned T2 pedometer=15 (25.4%) Women-only n=55 (32.5%) Received allocated intervention n=35 (63.6%) Did not receive allocated intervention n= 14 (25.4%) Did not attend n=5 (9.1%) Home-based n=55 (32.5%) Received allocated intervention n=24 (43.6%) Did not receive allocated intervention n= 25 (45.5%) Did not attend n=6 (10.9%) Mixed-sex n=59 (34.9%) Received allocated intervention n=39 (66.1%) Did not receive allocated intervention n=6 (10.2%) Did not attend n=14 (23.7%) Analysed survey n=38 (4 excluded due to no T1 survey) Analysed pedometer n=11 (4 excluded due to no T1 pedometer) Analysed survey n=32 Analysed pedometer n=12 (7 excluded due to no T1 pedometer) Analysed survey n=35 (3 excluded due to no T1 survey) Analysed pedometer n=15 (6 excluded due to no T1 pedometer) Characteristics Returned T2 survey Lost to follow-up Total n=116 (68.6%) n=53 (31.4%) n = 169 Sociodemographic Age, years (mean ± SD) 64.79 ± 9.57 61.10 ± 11.80 63.64 ± 10.42* Marital Status, n (% married) 50 (47.6%) 22 (56.4%) 72 (50.0%) Work Status, n (% retired) 56 (53.3%) 16 (41.0%) Ethnicity, n (% white) 65 (61.9%) 25 (64.1%) 90 (62.5%) Education, n (% post-secondary) 40 (38.1%) 14 (35.9%) 54 (37.5%) Gross Annual Family Income (% <$50,000 CDN) 58 (55.2%) 28 (71.8%) 86 (59.7%) Provide care to someone in household, n (% yes) 6 (9.1%) 10 (37%) 16 (17.2%)** Have children, n (% yes) 88 (85.4%) 32 (84.2%) 120 (85.1%) Clinical Indication for CR PCI (% yes) 56 (49.1%) 25 (49.0%) 81 (49.1%) Angina/ACS/CAD (% yes) 37 (33.0%) 22 (43.1%) 59 (36.2%) MI (% yes) 40 (35.4%) 19 (36.5%) 59 (35.8%) CABG (% yes) 29 (25.4%) 13 (25.5%) 42 (25.5%) Valve (% yes) 26 (23.0%) 6 (11.5%) 32 (19.4%) Risk Factors Dyslipidemia (% yes) 70 (84.3%) 34 (81.0%) 104 (83.2%) Hypertension (% yes) 68 (73.1%) 33 (80.5%) 101 (75.4%) Obesity 35 (44.9%) 14 (36.8%) 49 (42.2%) Diabetes 23 (28.8%) 15 (42.9%) 38 (33.0%) Comorbidities Musculoskeletal Impairment (% yes) 14 (15.9%) 6 (13.6%) 20 (15.2%) Depression (% yes) 10 (11.4%) 5 (11.6%) 15 (11.5%) Cancer (% yes) 6 (6.7%) 2 (4.9%) 8 (6.2%) Hyperthyroid (% yes) 4 (4.5%) 2 (4.8%) 6 (4.6%) Renal Disease (% yes) 2 (2.3%) 4 (3.1%) PAD/PVD (% yes) 1 (1.1%) 1 (2.4%) 2 (1.5%) Liver Disease (% yes) 0 (0.0%) 1 (0.8%) Intake Assessment Resting Heart Rate (BPM) 75.15 ± 14.80 76.38 ± 15.73 75.54 ± 15.06 Waist Circumference (cm) 92.53 ± 12.95 97.28 ± 16.42 94.15 ± 14.34 Peak METS 5.16 ± 2.08 4.73 ± 1.76 5.03 ± 1.99 Peak VO2 (mL/(kg•min) 18.10 ± 7.29 16.59 ± 6.17 17.62 ± 6.97 ANCOVA adjusted for baseline adherence, age and caregiving (p=.62); mean MMA score ± standard deviation where >2 indicates adherent patients DESIGN Single-blind, 3 parallel-arm ,pragmatic randomized controlled trial, with 1:1:1 allocation concealed. Female patients were randomized to 1 of 3 CR models at closest of 3 sites The randomization sequence was computer-generated, in blocks of 6, and stratified by cardiac condition. METHODS Low-risk female coronary artery disease patients were recruited from 6 inpatient and outpatient cardiac settings in the Greater Toronto Area of Ontario, Canada. Consenting participants completed a pre-program survey assessing health behaviours: Godin – self-reported physical activity Diet Habit Survey – eating habits Morisky – medication adherence Investigator-generated item – smoking behaviour Also wore a pedometer for 7 days Six months later participants were mailed a follow-up survey, and again wore a pedometer Pre-specified secondary objective of trial FINDINGS Patients walked over 6500 steps/day, were highly active, consumed low-fat diet, and were highly adherent to their medications (even pre- CR) There were few smokers (n=8; 4.7%) Overall there was a significant increase in self- reported PA pre to post CR (p<.001) There was a trend towards improved overall diet pre to post-program (p=.09). In the “intention-to-treat” analyses, there were no significant differences in any health behaviours by model (see Figs) LIMITATIONS: Potential selection bias – low-risk participants, interested in exercise Generalizability – other health care systems CONCLUSIONS Women’s health behaviours were either excellent pre-CR or significantly improved during CR, no matter which program model they participated in. 19 (11.7%) participants did not enroll in CR, and 43 (25.4%) attended a different model than the program to which they were randomly-allocated. *Denotes significant difference between pre and post-CR measures using t-tests or chi-squares p<.05; **p<.01; ***p<.001). Pedometer Step Count by Randomized Model Self-Reported Physical Activity by Randomized Model Diet Score by Randomized Model ANCOVA adjusted for baseline diet, age and caregiving (p=.51); mean DHS score ± standard deviation where >6500 is equivalent to 191-235 ≈ 25% fat diet ANCOVA adjusted for baseline steps, age, incidence of valve surgery, and intake peak VO2 values (p=.98); mean steps± standard deviation, where >6500 is equivalent to ~150 min MVPA/week ANCOVA adjusted for baseline Godin, age and caregiving (p=.42); mean Godin score ± standard deviation where >20 is equivalent to high PA